Box ManipulationIn the history of artificial intelligence and machine learning, the determination of internal parameters ...

Recursion Pharmaceuticals (NASDAQ:RXRX) reported updated clinical data for its investigational treatment for familial ...

For the past two years, the tech industry has been obsessed with AI copilots, assistants that write your code, draft... Read ...

Computer scientists have developed an automated evaluation pipeline that parses programming code into syntax graphs and uses ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

Recursion Pharmaceuticals RXRX, a TechBio company, is expected to beat expectations when it reports third-quarter 2026 results on Nov. 2, 2026. The Zacks Consensus Estimate is pegged at a loss of 24 ...

Recursion Pharmaceuticals (RXRX) news covers its AI-native Recursion OS, clinical pipeline, partnered programs, financial ...

Read about Recursive's Flint AI coding model, its laptop-friendly design, coding benchmarks, open-source license, and Eureka Machine technology.

A pedigree-based genetic evaluation of Pura Raza Española mares demonstrates that incorporating dominance deviations and inbreeding covariances improves phenotypic performance predictions and ...

Recursion Pharmaceuticals, Inc. announced that Sanofi has optioned the first development candidate from the two companies? multi-program research collaboration. The option triggered a $10 million ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

Good morning, everyone, and thank you for joining Recursion's Third Quarter Earnings Call. We're hosting earnings live from ...